Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nephro Care IndiaNSE:NEPHROCARE +2.29%48 ROA % is 1.38% as of Mar. 2026, which is 83% below its 10-year median of 8.01. GuruFocus rates NSE:NEPHROCARE with a GF Score™ of 48/100. The stock has 2 warning signs investors should review. Among 687 Healthcare Providers & Services companies, Nephro Care India ranks better than 50.07% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Nephro Care India's annualizedNet Income for the quarter that ended in Mar. 2026 was ₹10.0 Mil.
Nephro Care India's average Total Assets over the quarter that ended in Mar. 2026 was ₹727.2 Mil. Therefore, Nephro Care India's annualized ROA % for the quarter that ended in Mar. 2026 was 1.38%.
The historical rank and industry rank for Nephro Care India's ROA % or its related term are showing as below:
NSE:NEPHROCARE'
s ROA % Range Over the Past 10 Years
Min: -0.34 Med: 8.01 Max: 30.13
Current: 2.06
During the past 6 years, Nephro Care India's highest ROA % was 30.13%. The lowest was -0.34%. And the median was 8.01%.
NSE:NEPHROCARE's ROA % is ranked better than 50.07% of 687
companies
in the Healthcare Providers & Services industry
Industry Median: 2.05
vs NSE:NEPHROCARE: 2.06
Nephro Care India (NSE:NEPHROCARE) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is one times the annual (Mar. 2026) net income data. The Revenue data used here is one times the annual (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Nephro Care India ROA % Related Terms
Nephro Care India ROA % Historical Data
* Premium members only.
The historical data trend for Nephro Care India's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Nephro Care India's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nephro Care India ROA % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nephro Care India's ROA % distribution charts can be found below:
* The bar in red indicates where Nephro Care India's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is one times the annual (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Nephro Care India (NSE:NEPHROCARE) has a ROA % of 1.38% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Nephro Care India and its competitors. This is 83% below median its historical median of 8.01. According to the industry distribution chart, Nephro Care India ranks #343 out of 687 companies in the Healthcare Providers & Services industry, placing it in the top 49.9%.
Is Nephro Care India's ROA % too high?
Nephro Care India's current ROA % of 1.38% is 83% below median its 10-year median of 8.01. The Healthcare Providers & Services industry median ROA % is 2.05. Nephro Care India's value of 1.38% is 32.7% below this industry median. Based on the distribution chart, Nephro Care India ranks #343 out of 687 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Nephro Care India has a GF Score™ of 48/100, reflecting its overall financial health beyond just this single metric.
How does Nephro Care India's ROA % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Nephro Care India ranks #343 out of 687 companies for ROA %. This puts Nephro Care India in the upper half of its industry. The industry median ROA % is 2.05. Nephro Care India's value of 1.38% is 32.7% below this benchmark. While the company's 10-year median is 8.01 vs. the industry median of 2.05, Nephro Care India has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Healthcare Providers & Services company?
The median ROA % among Healthcare Providers & Services companies is 2.05, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nephro Care India's current ROA % of 1.38% is 32.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Nephro Care India and its competitors. For the Healthcare Providers & Services industry, the median ROA % is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nephro Care India's current ROA % is 1.38%, which is 83% below median its own 10-year median of 8.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nephro Care India stock overvalued right now?
Nephro Care India (NSE:NEPHROCARE) has a current ROA % of 1.38%. The current ROA % is 1.38%, which is 83% below median its 10-year median of 8.01 and 32.7% below the Healthcare Providers & Services industry median of 2.05. Nephro Care India's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Nephro Care India (NSE:NEPHROCARE), the current ROA % is 1.38% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Nephro Care India Ltd is a Kolkata-based healthcare provider specializing in comprehensive medical services for renal patients. The company serves as a one-stop treatment center, offering a broad spectrum of clinical and lifestyle solutions, along with specialized treatments for renal insufficiency. Its holistic care framework addresses not only the medical and physiological aspects of treatment but also focuses on lifestyle and spiritual wellness, providing an integrated approach to patient care.
48GF Score
Get the complete analysis for NSE:NEPHROCARE
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:NEPHROCARE has been successfully added to your 
